Intas launches biosimilar version of RituximabTimes of IndiaThis biosimilar version of Rituximab, competent in treating diseases characterized by excessive numbers of B cells, overactive B cells or dysfunctional B cells like chronic lymphocytic leukemi…
Rituximab joint protective benefits capped – from News-Medical.NetNews-Medical.netAs reported in Rheumatology, the researchers found that the likelihood for radiographic evidence of progressive RA structural damage to the hands and feet at 1 year was n…
|
Pregnant Women With High Celiac Disease Antibodies Are at Risk for Low Birth …
Science Daily (press release) Apr. 29, 2013 — Pregnant women with mid to high levels of antibodies common in patients with celiac disease are at risk for having babies with reduced fetal weight and birth weight, according to a new study in Gastroenterology, the official journal of … |
Biogen v. Glaxosmithkline: Prosecution History Disclaimer and Claim ConstructionPatently-ORituximab binds to this epitope. After Biogen filed its application, other scientists discovered that the CD20 antigen had a second small loop (originally thought…
|
Research Analysts’ Ratings Reiterations for April, 29th (ABBV, BJRI, CNA, GPK …
Zolmax In the meantime, the pipeline is advancing well, with a number of meaningful data readouts expected later this year (e.g., ABT-199 at ASCO, initial Hep-C phase-3 at AASLD in November) and in 2014 (e.g., Daclizumab phase-3).” BJ’s Restaurants (NASDAQ: … |
Goldman Sachs Raises PT on Abbvie (ABBV) to $52StreetInsider.com (subscription)For example, key pipeline assets in Hep C, elagolix and daclizumab could generate over $5.5 bn at peak (exhibit 1) while we have only $3.3 bn in our total 2020 pipeline esti…
|
UPDATE: BMO Capital Raises PT on AbbVie Following 1Q13 Earnings Call
Benzinga In the meantime, the pipeline is advancing well, with a number of meaningful data readouts expected later this year (e.g., ABT-199 at ASCO, initial Hep-C phase-3 at AASLD in November) and in 2014 (e.g., Daclizumab phase-3).” AbbVie closed on Friday at … Goldman Sachs Raises PT on Abbvie (ABBV) to $52StreetInsider.com (subscription) |
Fars News AgencyNanocomposites Used in Measurement of Human Serum AntibodiesFars News AgencyImmunoglobulin E (IgE) is an antibody found in very low levels in human blood and is secreted in response to immediate reactions triggered by the hypersensitivi…
|
Federal Circuit Finds Prosecution History Disclaimer In Enablement Arguments
Mondaq News Alerts (registration) The specification describes Biogen’s product Rituxan® (rituximab) as a preferred embodiment. Rituximab binds to a large loop of the CD20 protein that is exposed on the cell surface. This loop constitutes the particular “epitope” recognized by the … |
|
Botox May Become Less Effective After Prolonged Use – The Inquisitr
The Inquisitr Clinicians warn the repeated stimulation of antibodies, produced by the body’s immune system in response to foreign invaders, may eventually suppress the efficacy of Botox altogether. This means patients who require larger doses of the injections for … |